Literature DB >> 7577246

Inflammatory mediators of pain.

A Dray1.   

Abstract

While sensory fibres normally respond to a range of physical and chemical stimuli their activity and metabolism are profoundly altered by a variety of mediators generated by tissue injury and inflammation. These include substances produced by damaged tissue, substances of vascular origin as well as substances released by afferent fibres themselves, sympathetic fibres and various immune cells. The effects of inflammatory mediators, to activate or sensitize afferent fibres, are produced by changing membrane ion channels which are coupled directly via receptors or more commonly are regulated through receptor-coupled second messenger cascades. These latter processes also have the potential to alter gene transcription and thereby induce long-term alterations in the biochemistry of sensory neurones. This can have far-reaching consequences as the expression of novel proteins for ion channels (Na channels) and receptors (capsaicin, NPY) as well as the induction of novel enzymes (i-NOS) can profoundly affect the properties of nociceptors and their ability to transmit pain signals. However, such changes may be targeted successfully for the development of new analgesic and anti-inflammatory agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577246     DOI: 10.1093/bja/75.2.125

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  103 in total

1.  The 5-HT3 subtype of serotonin receptor contributes to nociceptive processing via a novel subset of myelinated and unmyelinated nociceptors.

Authors:  Karla P Zeitz; Nicolas Guy; Annika B Malmberg; Sahera Dirajlal; William J Martin; Linda Sun; Douglas W Bonhaus; Cheryl L Stucky; David Julius; Allan I Basbaum
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  The proteinase-activated receptor 2 is involved in nociception.

Authors:  W A Hoogerwerf; L Zou; M Shenoy; D Sun; M A Micci; H Lee-Hellmich; S Y Xiao; J H Winston; P J Pasricha
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 3.  What is the role of NSAIDs in pre-emptive analgesia?

Authors:  E Andrew Ochroch; Issam A Mardini; Allan Gottschalk
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs.

Authors:  Maxim Moreau; Jacques Dupuis; Norbert H Bonneau; Manon Lécuyer
Journal:  Can Vet J       Date:  2004-02       Impact factor: 1.008

5.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

Review 6.  Bladder sensory physiology: neuroactive compounds and receptors, sensory transducers, and target-derived growth factors as targets to improve function.

Authors:  Eric J Gonzalez; Liana Merrill; Margaret A Vizzard
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-04-23       Impact factor: 3.619

7.  Novel method to assess axonal excitability using channelrhodopsin-based photoactivation.

Authors:  Yi Zhu; Bin Feng; Erica S Schwartz; G F Gebhart; Steven A Prescott
Journal:  J Neurophysiol       Date:  2015-01-21       Impact factor: 2.714

8.  Anti-inflammatory and Anti-nociceptive Actions of Systemically or Locally Treated Adipose-Derived Mesenchymal Stem Cells in Experimental Inflammatory Model.

Authors:  Tufan Mert; Akif H Kurt; Mahmut Arslan; Ahmet Çelik; Berin Tugtag; Aysenur Akkurt
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

9.  Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis.

Authors:  Ruhin Yuridullah; Kimberly A Corrow; Susan E Malley; Margaret A Vizzard
Journal:  Auton Neurosci       Date:  2006-05-02       Impact factor: 3.145

10.  Urinary bladder function and somatic sensitivity in vasoactive intestinal polypeptide (VIP)-/- mice.

Authors:  Simon Studeny; Bopaiah P Cheppudira; Susan Meyers; Elena M Balestreire; Gerard Apodaca; Lori A Birder; Karen M Braas; James A Waschek; Victor May; Margaret A Vizzard
Journal:  J Mol Neurosci       Date:  2008-06-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.